Red-emitting polyaniline-based nanoparticle probe for pH-sensitive fluorescence imaging.


Journal

Biomaterials advances
ISSN: 2772-9508
Titre abrégé: Biomater Adv
Pays: Netherlands
ID NLM: 9918383886206676

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 29 05 2022
revised: 05 08 2022
accepted: 19 08 2022
pubmed: 30 8 2022
medline: 14 9 2022
entrez: 29 8 2022
Statut: ppublish

Résumé

Fluorescent probes based on semiconducting polymer nanoparticles (NPs) such as polyaniline (PANI) usually require external fluorophore doping to provide fluorescence function. Direct use of PANI-based NPs for bioimaging applications has been limited by PANI's weak blue fluorescence and aggregation-induced quenching in physiological medium. In this report, we developed a facile solid-state synthesis method to produce fluorescent polyaniline nanoparticles (FPNs) that are not only water-soluble but also exhibit high intensity and pH-sensitive red fluorescence. The FPNs showed high photoluminescence quantum yield (PLQY) of 19.3 % at physiological pH, which makes FPNs ideal for application as fluorescent nanoprobes in bioimaging. Moreover, we performed an in-depth study of photoluminescence dependence on pH and the phenomena of exciton-polaron quenching at low pH was highlighted. We also found that the ratio of emission intensity at 600 nm and 650 nm increased from 0.04 to 1.65 as pH was raised from 2.6 to 11.8, which could find its application in ratiometric pH sensing. FPNs exhibited excellent biocompatibility with >85 % cell viability for fibroblasts NIH/3 T3 and prostate cancer 22RV1 cells even at concentrations as high as 1000 μg/mL. In addition, fluorescence microscopy demonstrated concentration-dependent red fluorescence in the cytoplasm owing to the cellular uptake of FPNs in prostate cancer cells.

Identifiants

pubmed: 36037763
pii: S2772-9508(22)00365-X
doi: 10.1016/j.bioadv.2022.213088
pii:
doi:

Substances chimiques

Aniline Compounds 0
Fluorescent Dyes 0
polyaniline 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

213088

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Lokesh Yadav (L)

Department of Sustainable Energy Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, India.

Anjali Yadav (A)

Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, India.

Shovon Chatterjee (S)

Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur 208016, India.

Suhela Tyeb (S)

Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, India.

Raju Kumar Gupta (RK)

Department of Sustainable Energy Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, India; Department of Chemical Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, India; Centre for Environmental Science and Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, India.

Pratik Sen (P)

Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur 208016, India.

Bushra Ateeq (B)

Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, India; The Mehta Family Center for Engineering in Medicine, Indian Institute of Technology Kanpur, Kanpur 208016, India.

Vivek Verma (V)

Centre for Environmental Science and Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, India; Department of Materials Science and Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, India.

Kanwar S Nalwa (KS)

Department of Sustainable Energy Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, India. Electronic address: ksnalwa@iitk.ac.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH